key: cord-306646-6c7n0xir
authors: Crimi, Claudia; Impellizzeri, Pietro; Campisi, Raffaele; Spicuzza, Lucia; Vancheri, Carlo; Crimi, Nunzio
title: Resumption of Respiratory Outpatient Services in the COVID-19 era: experience from Southern Italy
date: 2020-07-02
journal: Am J Infect Control
DOI: 10.1016/j.ajic.2020.06.210
sha: 
doc_id: 306646
cord_uid: 6c7n0xir

COVID-19 pandemic turned the entire health-care system organization upside-down, suspending elective activities and outpatient services. In Italy, we are entering a second phase of the pandemic and several strategies has been developed to “re-open” the country, some businesses, and also health-care outpatient activities. This manuscript describes the experience of a Southern Italy Respiratory Unit for safely resuming outpatient respiratory services and preventing COVID-19 transmission.

Coronavirus disease 2019 (COVID-19) has quickly spread nationwide and has officially designated as a pandemic by World Health Organization (WHO) 1 . At the beginning of the outbreak, the need to contain transmission caused not only the lock-down of entire nations but also the shut-down of hospitals' outpatient care 2 .

The Sars-CoV-2 infection is mainly transmitted by respiratory droplets 3 and close contact, and both respiratory clinicians and patients are at increased risk for transmission during the outpatient visit and the pulmonary function testing procedures.

Patients scheduled for an outpatient visit may also suffer from common respiratory symptoms that can mimic or represent undiagnosed cases of COVID-19.

Planned pulmonary visit and pulmonary function tests (PFTs) were suspended and postponed unless when deemed clinically essential, as recommended by The American Thoracic Society, The Thoracic Society of Australia and New Zealand and The Irish Thoracic Society 4-7 , at the beginning of the pandemic.

In some realities, COVID-19 has rapidly changed the way of providing medical care, with hospitals providing "virtual visits" with remote consultations through video calls using commercially available software, to fill the gap with patients 8 .

Nevertheless, the ongoing medical needs of patients with pre-existing chronic respiratory diseases do not disappear during pandemics. Therefore, health-care organizations should implement strategies to respond to patients' needs proactively, while maintaining physical distancing policies, preventing infection transmission, and ensuring the safety of health-care workers at the same time.

In Italy, we are now experiencing a second phase of the pandemic where several efforts to cautiously "re-open" the country has been made, and despite restrictions start to ease, physical distancing is not to an untimely end and we cannot lower the guard. Therefore, a plan to manage the health issues of people with pre-existing chronic lung conditions is essential to prevent an inevitably indirect effect of COVID-19 on these frail patients that could be devastating, increasing deaths and disabilities. Moreover, a respiratory follow-up on patients who have recovered from COVID-19 pneumonia is pivotal in monitoring the possible fibrotic sequela of the disease 9 .

Many national/international professional organizations [4] [5] [6] [7] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] have released operational indications on how to plan the re-opening of pulmonary function test laboratories proponing different approaches, but the practical organization still relies on local hospital policies, when available or on practicing physicians.

We share our experience in planning for a resumption of the outpatient activity at the Respiratory Unit, Policlinico-Vittorio Emanuele, Catania, Italy. We believe that our model takes into account several practical operative problems and propose constructive and easy-to-adopt solutions. Table 1 summarizes the main challenges and identified solutions for restart respiratory outpatient clinics.

Patients will be informed telephonically and instructed to come on specific dates and times. At the entrance, an ad hoc trained "outpatient triage nurse" with adequate personal protective equipment (PPE) 19 will evaluate the patient providing a questionnaire for COVID-19 risk assessment, detecting temperature, and assigning a level of risk (high or low risk).

High-risk individuals will be referred to the emergency room department for nasopharyngeal swab testing and their outpatient visit rescheduled. This screening is an important aspect to consider since it might also trace under-recognized COVID-19 patients. Patients deemed at low risk will be provided with a surgical mask and an alcoholbased hand rub for hand hygiene and proceed to registration 19 . Pulmonologist evaluation will be carried out in a room with minimal furnishes, with physicians equipped with PPE, a stethoscope, a portable wireless echography probe for lung ultrasound evaluation, and an oximeter. Equipment will be disinfected with alcohol solutions between use for each patient 19 .

Pulmonary Function Tests will be performed in a room with a minimum presence of furnishings; the patient will be placed near the window with a plexiglass wall between he/she and the operator 9 . The technician will wear PPE 19 and sit in the same direction as the patient for protection in case of coughing or sneezing in the test area 9 .

Pulmonary Function Tests will be performed using disposable nose-clips and in-line antibacterial and viral filters 10 that will also serve as disposable mouthpieces, to prevent the transmission of infection from within the circuit. The bronchodilator testing will be performed using patients' salbutamol inhaler or a disposable aerochamber 20 .

Adequate ventilation of each room will be ensured using natural ventilation and an exhaust fan at the window to boost ventilation and direct airflow 21 . A 3D model of room design is shown in Figure 1 .

After each patient, adequate house-keeping and cleaning of the equipment and surfaces (e.g., exam bed, countertop, chair, equipment) with alcoholic solutions will be performed 19 , as well as safe waste management.

Pulmonary Function Tests will be performed only in essential cases for diagnosis of current illness, with immunocompromised patients tested first 7, 12, 14 . Early afternoon appointments will be scheduled for the most severe chronic respiratory patients. COVID-19 pneumonia recovered patients will be scheduled after at least 30 days of two consecutive negative swabs 13 .

We need to change the way we provided care to patients so far and co-habit with the "silent enemy", since chronic severe medical conditions still exist despite COVID-19, and we need to take care of them taking urgent and effective actions in continuing to assist chronic respiratory diseases while preventing infection dissemination.

The proposed approach represents a prudent and easy-to-reproduce plan to restart respiratory outpatient services while dealing with this prolonged health-care emergency.

We hope that our experience might provide a practical and useful guide for other respiratory units while resuming their respiratory outpatient activity. 

Critical preparedness, readiness and response actions for COVID-19: interim guidance. Date last updated: 22

Visualizing Speech-Generated Oral Fluid Droplets with Laser Light Scattering

Pulmonary Function Laboratories: Advice Regarding COVID-19. Date last updated

Date last updated: 24

Peak Respiratory Bodies recommend suspension of lung function testing. Date last updated. Date last accessed

Date last accessed

Virtually Perfect? Telemedicine for Covid-19

Clinical Respiratory Physiology, Chinese Association of Chest Physicians, Pulmonary Function Testing Group and R

Date last accessed

Le prove di funzionalità respiratoria nell'era della pandemia da COVID-19 -Position Paper Date last updated: 9

Recommendation from ERS Group 9.1 (Respiratory function technologists /Scientists) Lung function testing during COVID-19 pandemic and beyond. Date last updated: 09

Sociedade Portuguesa de Pneumologia. Recomenda es da SPP para a realiza o de provas funcionais respirat rias durante o surto COVID-19 Date last updated: 23

(PFT).pdf?date=04012020 19. WHO. Infection prevention and control during health care when COVID-19 is suspected. Interim guidance. Date last updated

Evaluation of Disposable and Traditional Accessory Devices for Use With a Pressurized Metered-Dose Inhaler

Natural ventilation for reducing airborne infection in hospitals

Acknowledgments: none.
